View our list of available Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) antibodies, recombinant proteins, ELISA Kits... Options Full Datasheet Printer Friendly Datasheet Prepare for Printing Full Datasheet Printer Friendly Datasheet Prepare for Printing Have Questions? Ask Us! Add To Compare List Hemagglutinin-Influenza B Virus Ohio 01/05 Recombinant Protein Catalog # MBS142731 Unit / Price DISCONTINUEDClick here to view our similar product(s) OR click here to contact our technical support team for suitable replacement. Product Name Product Info Accession #s Product Desc Diseases/Tissues/Pathways Applications References Product Name Hemagglutinin-Influenza B Virus Ohio 01/05, Recombinant Protein Full Product Name Recombinant Hemagglutinin-Influenza B Virus Ohio 01/05 Product Synonym Names Influenza-B Ohio; Influenza-B Virus Ohio 01/05 Recombinant; Ohio 01/05 Research Use Only For Research Use Only. Not for use in diagnostic procedures. TOP Host Baculovirus Insect Cells Purity/Purification Greater than 90.0% as determined by SDS-PAGE. Form/Format The Recombinant B/Ohio/01/05 solution contains 30mM Sodium phosphate, pH 7.4 and 50mM NaCl.Sterile Filtered colorless solution. Preparation and Storage B/Ohio/01/05 Recombinant should be stored at 4 degree C. Other Notes Small volumes of Hemagglutinin-Influenza B Virus Ohio 01/05 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply. TOP Related Product Information for Hemagglutinin-Influenza B Virus Ohio 01/05 recombinant protein Description: Recombinant Full-Length B/Ohio/01/05 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells.Introduction: Influenza-B virus is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift and reassortment. Influenza-B virus evolves slower than A viruses and faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, and a polymerasecomplex. Influenza B is sometimes spherical and sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin and neuraminidase.The Influenza B virus is 14648 nucleotideslong and consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, and the nucleocapsids are surrounded by one envelope. Product Categories/Family for Hemagglutinin-Influenza B Virus Ohio 01/05 recombinant protein Viral Antigens; INFLUENZA VIRUS; Viral Antigens; Influenza Applications Tested/Suitable for Hemagglutinin-Influenza B Virus Ohio 01/05 recombinant protein Western Blot (WB), ELISA (EIA) Application Notes for Hemagglutinin-Influenza B Virus Ohio 01/05 recombinant protein Immunological Activity: Western-Blot 0.1 ug -1 ug per strip, ELISA 1 ug/Well. TOP Precautions All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines. Disclaimer While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information. TOP